Omega Healthcare Investors Files 8-K

TL;DR

OHI filed an 8-K on 7/10/25 with updated corporate info.

AI Summary

Omega Healthcare Investors, Inc. filed an 8-K on July 10, 2025, reporting under Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the company's principal executive offices located at 303 International Circle, Suite 200, Hunt Valley, Maryland, 21030, with a business phone number of (410) 427-1700. The company is incorporated in Maryland and operates as a Real Estate Investment Trust.

Why It Matters

This 8-K filing provides updated corporate information and disclosures for Omega Healthcare Investors, Inc., which is important for investors tracking the company's regulatory compliance and operational details.

Risk Assessment

Risk Level: low — This filing is a routine 8-K providing corporate information and disclosures, not indicating any immediate financial distress or significant operational changes.

Key Players & Entities

• Omega Healthcare Investors, Inc. (company) — Registrant
• July 10, 2025 (date) — Date of earliest event reported
• 303 International Circle, Suite 200, Hunt Valley, Maryland, 21030 (location) — Address of principal executive offices
• 410-427-1700 (phone_number) — Registrant's telephone number

FAQ

From the Filing

0001104659-25-066856.txt : 20250710 0001104659-25-066856.hdr.sgml : 20250710 20250710083643 ACCESSION NUMBER: 0001104659-25-066856 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250710 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250710 DATE AS OF CHANGE: 20250710 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMEGA HEALTHCARE INVESTORS INC CENTRAL INDEX KEY: 0000888491 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction EIN: 383041398 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11316 FILM NUMBER: 251114912 BUSINESS ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 BUSINESS PHONE: 410-427-1700 MAIL ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 8-K 1 tm2520279d1_8k.htm FORM 8-K false 0000888491 0000888491 2025-07-10 2025-07-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549       FORM 8-K       CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): July 10, 2025   OMEGA HEALTHCARE INVESTORS, INC. (Exact name of registrant as specified in its charter)   Maryland 1-11316 38-3041398 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)   303 International Circle Suite 200 Hunt Valley , Maryland 21030 (Address of principal executive offices / Zip Code)   ( 410 ) 427-1700 (Registrant’s telephone number, including area code)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:     ¨ Written communications pursuant to Rule 425 under the Securities Act.     ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act.     ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.     ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.   Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:       Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $.10 par value OHI New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company  ¨   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨           Item 7.01 Regulation FD Disclosure.   On July 10, 2025, Omega Healthcare Investors, Inc. (“Omega” or the “Company”) issued a press release announcing that it had posted to its website, www.omegehealthcare.com, under the Investor Relations section and under the News & Events section, an updated investor presentation which includes a revised Operator Updates slide on page 9 of the presentation. The updated investor presentation is titled “July 2025 Investor Presentation.” The presentation will remain on the Company’s website for a period of at least thirty days. Omega’s press release is attached as Exhibit 99.1 to this Cu